Ether Lipid-Mediated Antioxidant Defense in Alzheimer's Disease.
Mariona JovéNatalia Mota-MartorellElia ObisJoaquim SolMeritxell Martin-GaríIsidro FerrerManuel Portero-OtinReinald PamplonaPublished in: Antioxidants (Basel, Switzerland) (2023)
One of the richest tissues in lipid content and diversity of the human body is the brain. The human brain is constitutively highly vulnerable to oxidative stress. This oxidative stress is a determinant in brain aging, as well as in the onset and progression of sporadic (late-onset) Alzheimer's disease (sAD). Glycerophospholipids are the main lipid category widely distributed in neural cell membranes, with a very significant presence for the ether lipid subclass. Ether lipids have played a key role in the evolution of the human brain compositional specificity and functionality. Ether lipids determine the neural membrane structural and functional properties, membrane trafficking, cell signaling and antioxidant defense mechanisms. Here, we explore the idea that ether lipids actively participate in the pathogenesis of sAD. Firstly, we evaluate the quantitative relevance of ether lipids in the human brain composition, as well as their role in the human brain evolution. Then, we analyze the implications of ether lipids in neural cell physiology, highlighting their inherent antioxidant properties. Finally, we discuss changes in ether lipid content associated with sAD and their physiopathological implications, and propose a mechanism that, as a vicious cycle, explains the potential significance of ether lipids in sAD.
Keyphrases
- oxidative stress
- fatty acid
- late onset
- ionic liquid
- single cell
- cell therapy
- dna damage
- endothelial cells
- early onset
- stem cells
- anti inflammatory
- ischemia reperfusion injury
- white matter
- risk assessment
- climate change
- induced apoptosis
- diabetic rats
- signaling pathway
- mass spectrometry
- high resolution
- human health
- pluripotent stem cells